The U.S. Food and Drug Administration (FDA) has officially banned the use of Red No. 3, also known as Erythrosine, in foods, dietary supplements, and ingested medicines. This decision follows …
"Cancer"
-
-
A new advisory released by U.S. Surgeon General Dr. Vivek Murthy warns of a direct link between alcohol consumption and a heightened risk of at least seven types of cancer. …
-
A recent study has identified links between common weed killers and prostate cancer, raising concerns about the safety of everyday lawn care products. The findings come after a $2.25 billion …
-
Colorectal cancer has long been seen as a disease affecting older adults, especially those over 65. But recent data shows rates of colorectal cancer are rising among adults under 50, …
-
The U.S. Food and Drug Administration (FDA) has recalled over 7,000 bottles of duloxetine, a widely used antidepressant, due to the discovery of a potentially cancer-causing chemical. The recall, initiated …
-
HealthNews
New Prostate Cancer Drug ‘CDKI-73’ Shows Promise in Treating Aggressive Forms, Study Finds
A new study reveals that a drug called CDKI-73 may offer an effective treatment for aggressive, drug-resistant prostate cancer, providing hope to men affected by the disease. Prostate cancer is …
-
A recent study by Australian health researchers predicts a sharp increase in male cancer cases and deaths worldwide by 2050. The number of male cancer cases is expected to rise …
-
Frequent marijuana users may face a significantly higher risk of developing head and neck cancers, according to a new study by the University of Southern California (USC). The study, published …
-
A new report from the American Cancer Society (ACS) reveals concerning trends: Generation X and millennials in the United States face a higher risk of developing 17 different types of …
-
The U.S. Food and Drug Administration (FDA) has approved a new blood test developed by Guardant Health to detect colorectal cancer. The test, named Shield, provides a less invasive and …